Aralez Pharmaceuticals Inc. (ARZ) Shares Down 6.5%

Aralez Pharmaceuticals Inc. (TSE:ARZ) shares dropped 6.5% on Monday . The stock traded as low as C$2.04 and last traded at C$2.14. Approximately 38,348 shares traded hands during trading, a decline of 9% from the average daily volume of 42,136 shares. The stock had previously closed at C$2.01.

COPYRIGHT VIOLATION NOTICE: This story was published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://transcriptdaily.com/2017/11/27/aralez-pharmaceuticals-inc-arz-shares-down-6-5.html.

About Aralez Pharmaceuticals

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

Receive News & Ratings for Aralez Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply